Literature DB >> 8368750

Assessment of immunologic competence and host reactivity against tumor antigens in breast cancer patients. Prognostic value and rationale of immunotherapy development.

J F Head1, F Wang, R L Elliott, J L McCoy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8368750     DOI： 10.1111/j.1749-6632.1993.tb44024.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  Comparison of estrogen and progesterone receptor status to lymphocyte immunity against tumor antigens in breast cancer patients.

Authors:  R L Elliott; J F Head; J L McCoy
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

2.  Relationship of serum and tumor levels of iron and iron-binding proteins to lymphocyte immunity against tumor antigen in breast cancer patients.

Authors:  R L Elliott; J F Head; J L McCoy
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.